Carcinoembryonic antigen

Jump to: navigation, search
carcinoembryonic antigen-related cell adhesion molecule 5
Identifiers
Symbol CEACAM5
Alt. Symbols CEA
Entrez 1048
HUGO 1817
OMIM 114890
RefSeq NM_004363
UniProt P06731
Other data
Locus Chr. 19 q13.1-13.2

WikiDoc Resources for

Carcinoembryonic antigen

Articles

Most recent articles on Carcinoembryonic antigen

Most cited articles on Carcinoembryonic antigen

Review articles on Carcinoembryonic antigen

Articles on Carcinoembryonic antigen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Carcinoembryonic antigen

Images of Carcinoembryonic antigen

Photos of Carcinoembryonic antigen

Podcasts & MP3s on Carcinoembryonic antigen

Videos on Carcinoembryonic antigen

Evidence Based Medicine

Cochrane Collaboration on Carcinoembryonic antigen

Bandolier on Carcinoembryonic antigen

TRIP on Carcinoembryonic antigen

Clinical Trials

Ongoing Trials on Carcinoembryonic antigen at Clinical Trials.gov

Trial results on Carcinoembryonic antigen

Clinical Trials on Carcinoembryonic antigen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Carcinoembryonic antigen

NICE Guidance on Carcinoembryonic antigen

NHS PRODIGY Guidance

FDA on Carcinoembryonic antigen

CDC on Carcinoembryonic antigen

Books

Books on Carcinoembryonic antigen

News

Carcinoembryonic antigen in the news

Be alerted to news on Carcinoembryonic antigen

News trends on Carcinoembryonic antigen

Commentary

Blogs on Carcinoembryonic antigen

Definitions

Definitions of Carcinoembryonic antigen

Patient Resources / Community

Patient resources on Carcinoembryonic antigen

Discussion groups on Carcinoembryonic antigen

Patient Handouts on Carcinoembryonic antigen

Directions to Hospitals Treating Carcinoembryonic antigen

Risk calculators and risk factors for Carcinoembryonic antigen

Healthcare Provider Resources

Symptoms of Carcinoembryonic antigen

Causes & Risk Factors for Carcinoembryonic antigen

Diagnostic studies for Carcinoembryonic antigen

Treatment of Carcinoembryonic antigen

Continuing Medical Education (CME)

CME Programs on Carcinoembryonic antigen

International

Carcinoembryonic antigen en Espanol

Carcinoembryonic antigen en Francais

Business

Carcinoembryonic antigen in the Marketplace

Patents on Carcinoembryonic antigen

Experimental / Informatics

List of terms related to Carcinoembryonic antigen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers.

Pathophysiology

CEA and related genes make up the CEA family belonging to the immunoglobulin superfamily. In humans, the carcinoembryonic antigen family consists of 29 genes, 18 of which are normally expressed. [2]

Historical perspective

CEA was first identified in 1965 by Phil Gold and Samuel O. Freedman in human colon cancer tissue extracts.[3] It was found that serum from individuals with colorectal, gastric, pancreatic, lung and breast carcinomas had higher levels of CEA than healthy individuals.

Diagnosis

CEA measurement is mainly used as a tumor marker to identify recurrences after surgical resection. Elevated CEA levels should return to normal after surgical resection, as elevation of CEA during follow up is an indicator of recurrence of tumour.

Differential Diagnosis

In alphabetical order. [4] [5]

Increased

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  2. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9:67-81. PMID 10202129.
  3. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439. PMID 14270243.
  4. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  5. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X
Cost Effectiveness of Carcinoembryonic antigen

| group5 = Clinical Trials Involving Carcinoembryonic antigen | list5 = Ongoing Trials on Carcinoembryonic antigen at Clinical Trials.govTrial results on Carcinoembryonic antigenClinical Trials on Carcinoembryonic antigen at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Carcinoembryonic antigen | list6 = US National Guidelines Clearinghouse on Carcinoembryonic antigenNICE Guidance on Carcinoembryonic antigenNHS PRODIGY GuidanceFDA on Carcinoembryonic antigenCDC on Carcinoembryonic antigen


| group7 = Textbook Information on Carcinoembryonic antigen | list7 = Books and Textbook Information on Carcinoembryonic antigen


| group8 = Pharmacology Resources on Carcinoembryonic antigen | list8 = AND (Dose)}} Dosing of Carcinoembryonic antigenAND (drug interactions)}} Drug interactions with Carcinoembryonic antigenAND (side effects)}} Side effects of Carcinoembryonic antigenAND (Allergy)}} Allergic reactions to Carcinoembryonic antigenAND (overdose)}} Overdose information on Carcinoembryonic antigenAND (carcinogenicity)}} Carcinogenicity information on Carcinoembryonic antigenAND (pregnancy)}} Carcinoembryonic antigen in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Carcinoembryonic antigen


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Carcinoembryonic antigen | list9 = AND (pharmacogenomics)}} Genetics of Carcinoembryonic antigenAND (pharmacogenomics)}} Pharmacogenomics of Carcinoembryonic antigenAND (proteomics)}} Proteomics of Carcinoembryonic antigen


| group10 = Newstories on Carcinoembryonic antigen | list10 = Carcinoembryonic antigen in the newsBe alerted to news on Carcinoembryonic antigenNews trends on Carcinoembryonic antigen</small>


| group11 = Commentary on Carcinoembryonic antigen | list11 = Blogs on Carcinoembryonic antigen

| group12 = Patient Resources on Carcinoembryonic antigen | list12 = Patient resources on Carcinoembryonic antigenDiscussion groups on Carcinoembryonic antigenPatient Handouts on Carcinoembryonic antigenDirections to Hospitals Treating Carcinoembryonic antigenRisk calculators and risk factors for Carcinoembryonic antigen


| group13 = Healthcare Provider Resources on Carcinoembryonic antigen | list13 = Symptoms of Carcinoembryonic antigenCauses & Risk Factors for Carcinoembryonic antigenDiagnostic studies for Carcinoembryonic antigenTreatment of Carcinoembryonic antigen

| group14 = Continuing Medical Education (CME) Programs on Carcinoembryonic antigen | list14 = CME Programs on Carcinoembryonic antigen

| group15 = International Resources on Carcinoembryonic antigen | list15 = Carcinoembryonic antigen en EspanolCarcinoembryonic antigen en Francais

| group16 = Business Resources on Carcinoembryonic antigen | list16 = Carcinoembryonic antigen in the MarketplacePatents on Carcinoembryonic antigen

| group17 = Informatics Resources on Carcinoembryonic antigen | list17 = List of terms related to Carcinoembryonic antigen


}}


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox